cephalosporin c has been researched along with Black Death in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (75.00) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Biek, D; Halasohoris, SA; Hannah, B; Lembirik, S; Lemmon, MM; Panchal, RG; Pysz, LM; Scarff, JM; Zumbrun, SD | 1 |
| Anisimov, BI; Moldavan, IA; Ryzhko, IV; Shcherbaniuk, AI; Trishina, AV; Tsuraeva, RI | 1 |
| Bardakhch'ian, EA; Pasiukov, VV; Ryzhko, IV; Samokhodkina, ED | 1 |
| Pasiukov, VV; Ryzhko, IV; Samokhodkina, ED; Shcherbaniuk, AI; Tsuraeva, RI | 1 |
| Kasatkina, IV; Pasiukov, VV; Roshchina, NV; Ryzhko, IV; Samokhodkina, ED; Shcherbaniuk, AI; Tsetskhladze, NS; Tsuraeva, RI | 1 |
| Makarovskaia, LN; Markovskaia, EI; Ryzhkova, VV; Sorokina, TB; Zurabian, VA | 1 |
| Ryzhko, IV; Samokhodkina, ED; Shcherbaniuk, AI; Tsetskhladze, NS; Tsuraeva, RI | 1 |
| Auregan, G; Burgel, PR; Camara, P; Hovette, P; Klotz, F; Sane, M | 1 |
8 other study(ies) available for cephalosporin c and Black Death
| Article | Year |
|---|---|
In vitro and in vivo activity of GT-1, a novel siderophore cephalosporin, and GT-055, a broad-spectrum β-lactamase inhibitor, against biothreat and ESKAPE pathogens.
Topics: Animals; Anti-Bacterial Agents; beta-Lactamase Inhibitors; Biological Warfare Agents; Cephalosporins; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Plague; Siderophores; Yersinia pestis | 2021 |
[Efficacy of cefixime and cefepime vs. other cephalosporins in experimental plague of albino mice due to variants FI+ and FI- of the plague microbe].
Topics: Animals; Anti-Bacterial Agents; Antigens, Bacterial; Bacterial Capsules; Cefepime; Cefixime; Cephalosporins; Dose-Response Relationship, Drug; Mice; Plague; Species Specificity; Yersinia pestis | 2007 |
[Ultrastructural changes in liver of white mice, caused by isogenic F1+ and F1- strains of the plague pathogen, and correction of them with ceftriaxone].
Topics: Animals; Ceftriaxone; Cephalosporins; Liver; Mice; Microscopy, Electron; Plague; Yersinia pestis | 1996 |
[Third generation cephalosporins (cefoperazone, cefotaxime, ceftazidime and ceftriaxone) in the prevention and treatment of experimental plague in albino mice].
Topics: Animals; Cefoperazone; Cefotaxime; Ceftazidime; Ceftriaxone; Cephalosporins; Drug Evaluation, Preclinical; Mice; Microbial Sensitivity Tests; Plague; Treatment Outcome; Yersinia pestis | 1996 |
[A comparative study of fluoroquinolones and 3rd-generation cephalosporins in the prevention and treatment of experimental plague caused by Yersinia pestis strains typical and serologically atypical with respect to F1].
Topics: Animals; Anti-Infective Agents; Antigens, Bacterial; Bacterial Capsules; Cephalosporins; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Fluoroquinolones; Mice; Plague; Time Factors; Yersinia pestis | 1997 |
[Pathomorphological changes in albino mice infected with plague and treated with cefotaxime].
Topics: Animals; Cefotaxime; Cephalosporins; Liver; Lung; Lymph Nodes; Mice; Plague; Spleen | 1998 |
[Characteristics of etiotropic therapy of plaque infection induced by atypical strains of F1- phenotype plaque microbe].
Topics: Aminoglycosides; Ampicillin; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibiotics, Antitubercular; Antigens, Bacterial; Aztreonam; Bacterial Proteins; Cephalosporins; Disease Models, Animal; Doxycycline; Fluoroquinolones; Mice; Monobactams; Penicillins; Phenotype; Plague; Rifampin | 1998 |
[Pulmonic plague].
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Cephalosporins; Child, Preschool; Diagnosis, Differential; Fluoroquinolones; Humans; Infant; Plague; Pneumonia, Bacterial; Streptomycin | 1998 |